Alnylam Pharmaceuticals, Inc. (BVMF:A1LN34)

Alnylam Pharmaceuticals Statistics

Total Valuation

BVMF:A1LN34 has a market cap or net worth of BRL 226.56 billion. The enterprise value is 226.87 billion.

Market Cap	226.56B
Enterprise Value	226.87B

Important Dates

The last earnings date was Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+5.51%
Shares Change (QoQ)	-0.78%
Owned by Insiders (%)	0.34%
Owned by Institutions (%)	98.79%
Float	132.12M

Valuation Ratios

The trailing PE ratio is 131.10 and the forward PE ratio is 33.27.

PE Ratio	131.10
Forward PE	33.27
PS Ratio	11.08
PB Ratio	52.12
P/TBV Ratio	52.12
P/FCF Ratio	88.38
P/OCF Ratio	78.48
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 70.00, with an EV/FCF ratio of 88.50.

EV / Earnings	131.28
EV / Sales	11.90
EV / EBITDA	70.00
EV / EBIT	88.15
EV / FCF	88.50

Financial Position

The company has a current ratio of 2.76, with a Debt / Equity ratio of 3.76.

Current Ratio	2.76
Quick Ratio	2.51
Debt / Equity	3.76
Debt / EBITDA	4.70
Debt / FCF	6.38
Interest Coverage	1.99

Financial Efficiency

Return on equity (ROE) is 73.28% and return on invested capital (ROIC) is 86.03%.

Return on Equity (ROE)	73.28%
Return on Assets (ROA)	6.81%
Return on Invested Capital (ROIC)	86.03%
Return on Capital Employed (ROCE)	14.33%
Weighted Average Cost of Capital (WACC)	6.32%
Revenue Per Employee	8.18M
Profits Per Employee	691,247
Employee Count	2,500
Asset Turnover	0.81
Inventory Turnover	8.46

Taxes

In the past 12 months, BVMF:A1LN34 has paid 51.80 million in taxes.

Income Tax	51.80M
Effective Tax Rate	2.91%

Stock Price Statistics

The stock price has increased by +5.97% in the last 52 weeks. The beta is 0.35, so BVMF:A1LN34's price volatility has been lower than the market average.

Beta (5Y)	0.35
52-Week Price Change	+5.97%
50-Day Moving Average	110.55
200-Day Moving Average	97.75
Relative Strength Index (RSI)	35.42
Average Volume (20 Days)	180

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.41

Income Statement

In the last 12 months, BVMF:A1LN34 had revenue of BRL 20.46 billion and earned 1.73 billion in profits. Earnings per share was 12.83.

Revenue	20.46B
Gross Profit	16.70B
Operating Income	2.76B
Pretax Income	1.78B
Net Income	1.73B
EBITDA	3.07B
EBIT	2.76B
Earnings Per Share (EPS)	12.83

Balance Sheet

The company has 16.02 billion in cash and 16.35 billion in debt, with a net cash position of -332.21 million.

Cash & Cash Equivalents	16.02B
Total Debt	16.35B
Net Cash	-332.21M
Net Cash Per Share	n/a
Equity (Book Value)	4.35B
Book Value Per Share	32.84
Working Capital	14.23B

Cash Flow

In the last 12 months, operating cash flow was 2.89 billion and capital expenditures -323.30 million, giving a free cash flow of 2.56 billion.

Operating Cash Flow	2.89B
Capital Expenditures	-323.30M
Free Cash Flow	2.56B
FCF Per Share	n/a

Margins

Gross margin is 81.64%, with operating and profit margins of 13.51% and 8.45%.

Gross Margin	81.64%
Operating Margin	13.51%
Pretax Margin	8.70%
Profit Margin	8.45%
EBITDA Margin	15.00%
EBIT Margin	13.51%
FCF Margin	12.53%

Dividends & Yields

BVMF:A1LN34 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.51%
Shareholder Yield	-5.51%
Earnings Yield	0.76%
FCF Yield	1.13%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BVMF:A1LN34 has an Altman Z-Score of 6.35 and a Piotroski F-Score of 5.

Altman Z-Score	6.35
Piotroski F-Score	5